H.U. GROUP HOLDINGS INC.

Company Snapshot

Founded: 1950

Entity Type: Public

Employees: 5,444

Region: Japan

Revenue: $1,596.7 Millions

Revenue Year: 2024

Headquarter: Tokyo, Japan

Key Geographics: Japan

Corporate Address: Akasaka Intercity AIR, 1-8-1, Akasaka, Minato-ku, Tokyo 107-0052, Japan Tel. +81-3-6279-0801 www.hugp.com

Company Overview

Founded in 1950, H.U. Group Holdings Inc. is a group company that offers lab testing and its related Services (LTS), IVDs, and added healthcare services (HS). The IVD business is a leading company in immunoassay reagents, providing products to over 100 countries worldwide.

Fujirebio, a member of H.U. Group Holdings Inc. and a leading provider of IVD testing produces over 250 million test results per year. Fujirebio offers products and solutions for a range of diseases and disorders, including metabolic disorders, infectious diseases, immune response disorders, neurodegenerative conditions, and oncology, among others.

Fujirebio was the first company to develop and market CSF biomarker tests for AD under the Innogenetics brand, over 25 years ago. These tests have evolved from research tools to specialized diagnostic products. Today, the company offers a full range of Alzheimer’s products designed for use on automated systems. Its portfolio includes Lumipulse CSF tests, Lumipulse blood-based tests, and ultra-high-sensitivity platform tests.

Financial Highlights (FY 2024)

Net Revenue: ***

Total Current Liabilities: ***

Total Current Assets: ***

Operating Income: ***

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member